What Does Robotic Surgery System Cost?

Capital acquisition spans $750k–$2.5M; recurring instrument and service costs add $3,000–$3,500 per case. Total first-year spend often exceeds $4M including installation, training, and maintenance contracts.

Robotic surgery systems remain among the highest-capital medical device acquisitions, but the market is no longer monolithic. Intuitive's da Vinci 5, the latest release from the largest surgical robotic manufacturer, has a price of $1.8 to $2.5 million . Newer competitors are deliberately pricing lower. CMR Surgical Versius is estimated between $0.75 million and $1 million, Stryker Mako between $0.8 million and $1.4 million, and Zimmer Biomet ROSA between $1 million and $1.5 million . Orthopedic and spine platforms often fall within these tighter bands, while general-surgery capable systems command premium pricing.

In December 2025, Medtronic's Hugo robotic system received US Food and Drug Administration clearance to be sold to hospitals, marking a potential major shift in the market . This entry has introduced pricing pressure and modular design alternatives that may reshape vendor negotiations by Q3 2026.

Note: MedSource does not yet have aggregate competitive quotes for robotic systems. Pricing below reflects published list prices, used-equipment market rates, and publicly filed financial statements. Actual acquisition cost depends heavily on GPO membership, trade-in allowance, and contract type (capital purchase vs. lease vs. per-case pay model).

What the typical range is

New capital purchase (da Vinci systems, dominant market):

Acquisition costs of a da Vinci range between $0.5 and $2.5 million, depending on model, configuration, and location .

• da Vinci SP (single-port): ~$1.5–$1.8M
• da Vinci Xi (multiport, flagship): ~$1.8–$2.3M
• da Vinci 5 (latest generation): $1.8 to $2.5 million

New capital purchase (competing platforms):

CMR Surgical Versius: $0.75–$1M; Stryker Mako: $0.8–$1.4M; Zimmer Biomet ROSA: $1–$1.5M

Used/refurbished systems:

Refurbished systems available at 30–70% discount off new pricing , typically ranging $500k–$1.2M for functional da Vinci Xi/X units.

Annual recurring costs (service + instruments):

Annual service fees up to $190,000 and recurring cost of instruments and accessories at $600–$3,500 per surgical procedure .

• Per-case instrument cost averages $1,866 for robotic surgery (2017 data, likely higher now).

Operating room buildout and training (year one, additional to capital):

• OR infrastructure upgrades: $200k–$500k
• Surgeon credentialing and team training: $50k–$150k
• Installation and equipment certification: $25k–$100k

Total first-year financial impact: $2.2M–$4.5M for a new da Vinci system at a mid-size hospital, including capital, installation, service contract, and 100 procedures.

What pushes price up — features, certifications, support tier

System generation and capability:

Da Vinci 5 brings more than 150 design innovations and 10,000x the computing power of da Vinci Xi . Newer systems cost 15–25% more than prior generations but enable additional procedure types (e.g., hybrid robotic–fluoroscopy fusion for spine).

Configuration and arm count: Multiport systems with four robotic arms cost more than single-port or three-arm configurations. Fixed-tower design (da Vinci) costs more upfront than mobile-cart architecture (Hugo, Versius), which may enable faster deployment across multiple ORs.

Integrated imaging and navigation:

Stryker's Mako systems use an AI technology called Blueprint that helps surgeons better understand shoulder deformities and predict potential challenges . Premium imaging integration (intraoperative CT, real-time tracking) adds $200k–$500k.

Service tier and support response time: Standard contracts (4–8 hour response): $100k–$150k/year. Premium contracts (1–2 hour on-site response, 24/7 support): $150k–$190k/year. Extended warranty and parts availability: +$20k–$50k/year.

Training and adoption packages: Included training for first 4 surgeons typically bundled in capital purchase. Additional surgeon credentialing: $10k–$15k per physician. Hands-on proficiency simulator (da Vinci Skills) access: $30k–$100k/year depending on license breadth.

Regulatory and validation burden: Systems with FDA 510(k) clearance for broader indications (urology, gynecology, general, thoracic, colorectal) carry less re-validation cost than single-indication systems. Spinal or cardiac integration requires additional regulatory documentation and facility accreditation, raising effective acquisition cost by $50k–$150k.

What pushes price down — refurbished, older generation, lease, GPO contracts

Refurbished or pre-owned units:

R2 Surgical offers 30–70% off on the latest robotics systems, including used robots and refurbished robots . A 2–3 year old da Vinci Xi in good operating condition may sell for $700k–$1.2M. Warranty and service terms typically reset or require extended coverage purchase; total five-year cost-of-ownership may approach new unit pricing if major component replacement occurs.

Older da Vinci generation (X, Si, S):

• da Vinci X (single-site focus): $1–$1.4M used, $1.3–$1.6M new
• da Vinci Si (2009 legacy): $400k–$700k used
• Models >10 years old: $200k–$500k but face rising spare-parts costs and potential end-of-life support risk

Lease or pay-per-case models:

Manufacturers are offering a 'pay-per-click model,' where the cost of the unit is spread out over the purchase contract and the number of cases being performed, with hospitals paying a fee every time a robotic case is completed and amortizing the cost over 7 years . Effective cost per case: $2,500–$4,000 (capital + service amortized), with no upfront purchase. This model suits smaller hospitals or those testing market demand.

CMR Surgical Versius (modular, lease-focused):

Versius is mainly supplied through leasing contracts, covering the robot and all associated costs, and allegedly comes at 60–70% of the competitors' lifetime cost . Exact lease terms not publicly disclosed; available only in select markets (EU, selected US pilot sites as of May 2026).

Group Purchasing Organization (GPO) contracts: Health systems with large GPO leverage (e.g., Premier, Vizient) typically negotiate 10–20% discounts on capital price plus bundled service rates. Service tiers may compress $190k/year contracts to $140k–$160k/year. Instrument pricing through GPOs may achieve volume discounts of 5–15%.

Trade-in allowance: Replacing an older da Vinci or competing platform may unlock $100k–$300k trade-in credit toward new da Vinci 5 purchase, reducing net cash outlay.

Hidden costs — install, training, calibration, consumables, service contracts

Installation and OR preparation:

• Equipment delivery and setup: $15k–$25k
• Electrical and network infrastructure: $50k–$150k (depends on existing OR design)
• Hardware integration with existing EMR/OR management systems: $25k–$75k
• Regulatory inspection and facility accreditation (if required): $10k–$30k

Surgeon credentialing and training (per-physician):

Cost of training first four surgeons is included in the purchase price of the robot . Additional surgeons: $8k–$15k each (simulator time, wet lab, proctor fees). Learning curve: 50–200 cases to achieve proficiency depending on surgical specialty and prior laparoscopic experience.

Team training (OR nursing, technician, anesthesia coordination):

• Initial training: $20k–$40k
• Annual refresher and competency assessment: $5k–$10k/year

Instruments and consumables per case:

Recurring cost of instruments and accessories at $600–$3,500 per surgical procedure . Breakdown:

• EndoWrist instruments (reusable, finite lifetime ~10–14 uses): $400–$1,200 per case
• Disposable items (drapes, stapler cartridges, specimen bags): $200–$800 per case
• Endoscopes (replacement cycle ~18–24 months): $8k–$15k per scope
• Simulator consumables: $2k–$5k/year

Service and maintenance contracts (annual):

Maintenance costs can range from $100,000 to $200,000 annually, depending on the service contract and the specific needs of the system . This covers:

• Preventive maintenance (4–6 visits/year)
• Software updates
• Emergency repair and parts (subject to negotiated caps)
• Loaner unit availability (optional add-on, +$10k–$20k/year)

Software licensing and data analytics:

Intuitive Surgical has an AI tool for the da Vinci 5 called Case Insights that can analyze surgical procedures and provide surgeons with post-surgical feedback . Advanced analytics licenses and case-logging subscriptions: $15k–$40k/year.

Regulatory and compliance documentation: Annual credentialing review, infection control audits, adverse event reporting: $5k–$15k/year (internal labor; may require external compliance consulting in large systems).

Estimated total cost of ownership, first 5 years:

Cost Category	Year 1	Years 2–5 (annual)	5-Year Total
Capital (new da Vinci)	$1,800,000	—	$1,800,000
Installation/setup	$150,000	—	$150,000
Service contract	$150,000	$150,000	$750,000
Surgeon training (4 surgeons)	$30,000	$10,000	$70,000
Team training	$30,000	$5,000	$50,000
Consumables (200 cases/year)	$374,000	$374,000	$1,870,000
Software/analytics	$20,000	$20,000	$100,000
TOTAL	$2,554,000	$559,000	$4,790,000

Per-case cost: $4,790,000 ÷ 1,000 cases = $4,790/case (excluding surgeon/facility fees).

How to negotiate — concrete tactics

1. Establish GPO membership early. Hospitals not on a major GPO miss 10–20% pricing leverage. Verify membership in Premier, Vizient, HealthTrust, or regional coalitions before finalizing vendor selection.

2. Benchmark against competing platforms. Obtain quotes from Intuitive (da Vinci 5), Medtronic (Hugo RAS), and Stryker (Mako, if orthopedic-focused). Use competing bids to negotiate capital price reductions. In early 2026, Hugo's recent FDA clearance has incentivized da Vinci price concessions in soft-tissue surgery markets.

3. Separate capital, service, and instrument pricing. Request unbundled quotes:

• Capital system only
• Separate service contract terms (standard vs. premium response time)
• Instrument list pricing (per EndoWrist set, per disposable type)
• Negotiate instruments separately if volume >150 cases/year; volume discounts may apply

4. Negotiate trade-in allowance on existing equipment. If replacing an older da Vinci or competitor system, secure written trade-in valuation (typically $100k–$250k for a working Xi or X model). Apply credit to new system capital cost.

5. Explore lease or pay-per-case models. For hospitals with capital budget constraints or uncertain case volume, request full amortization via operating lease (typically 5–7 year terms at 10–15% discount vs. purchase NPV) or per-case pricing ($2,500–$4,000/case amortized). Compare 7-year total cost to capital purchase.

6. Negotiate service tier and response time. Standard 4–8 hour response may not suit all ORs. Request tiered options:

• Standard: $140k/year (4–8 hour response, business days)
• Plus: $160k/year (24-hour response, spare parts buffer, loaner availability)
• Premium: $180k/year (2-hour response, dedicated technician visits) Choose based on case volume and OR criticality.

7. Bundle training into capital contract. Confirm first four surgeons + core OR team training is included in purchase price. Negotiate additional surgeon credentialing at flat fee ($8k/surgeon) rather than hourly proctor rates.

8. Lock in multi-year instrument pricing. Negotiate fixed per-unit prices on EndoWrist instruments and disposables for 2–3 years. Secure volume discounts (e.g., $950/case at 150+ cases/year; $1,050/case at 75–149 cases/year).

9. Request extended warranty and parts buffer. Negotiate manufacturer warranty from standard 1 year to 3 years on capital components. Request parts depot credit ($25k–$50k) to cover surprise repairs and reduce downtime risk.

10. Clarify IP and software licensing. Verify rights to case data, analytics, and training recordings. Ensure software updates are perpetual (not subscription-gated) post-purchase. Confirm compliance with EHR integration and data security standards (HIPAA, IEC 62304 for medical device software).

When the price feels off — red flags

Asking price >$2.8M for da Vinci 5 without bundled service or training: Baseline capital cost should be $1.8–$2.5M. Prices >$2.8M suggest markup for installation, training, or extended warranty; request itemized breakdown. If vendor cannot justify above $2.5M, walk and obtain competing bids.

Service contracts >$200k/year without premium support features: Standard 4–8 hour response should not exceed $150k/year as of May 2026. If quoted >$180k/year, request detailed scope (parts coverage, response SLA, loaner terms) or negotiate downward 10–20%.

Instrument pricing >$2,000 per case after volume negotiation: Published per-case cost (capital + service + instruments amortized) is $3,500–$4,500. If a vendor quotes instruments alone at >$2,000/case, check if EndoWrist reuse limits are artificially low (e.g., claiming 5 uses vs. industry standard 10–14). Request manufacturer data on actual instrument lifespan.

Refurbished system quoted without reset warranty or service history: Pre-owned systems should include 1–2 year warranty and full service history documentation. Avoid units >5 years old without clear parts-availability roadmap. Request loaner coverage during repairs.

Lease terms without clear case-volume assumptions: Per-case lease models assume 150–200 cases/year to be cost-neutral vs. purchase. If your hospital averages <100 cases/year, lease may cost 20–30% more than purchase over 5 years. Run amortization analysis.

Hugo RAS quoted at >$1.8M or Versius without site visit and CE-mark documentation: Hugo is positioned as lower-cost; pricing >$1.8M suggests markup or bundled services. Versius availability is limited; confirm FDA/CE clearance for your procedure scope and ask for reference sites with >6 months operational data.

Surgeon training cost >$15k per additional physician after the initial four: Training costs should be flat-rate and included or capped. Hourly proctor rates often exceed $500/hour; cap individual surgeon training at $8k–$12k total (simulator time + 1–2 proctor visits).

Sources

American College of Surgeons (February 2026). "Cost of Robotic Surgery Remains Complex Equation." Based on Intuitive Surgical financial disclosures and 2024 operational data.

International Journal of Abdominal Wall and Hernia Surgery (June 2023). "Do the costs of robotic surgery present an insurmountable barrier?" Synthesis of manufacturer data and health system cost analyses.

Intuitive Surgical SEC filings and Medtronic FDA clearance documents (December 2025).

JAMA Surgery (2018). Childers et al. Hospital-level cost analysis using Intuitive Surgical financial statements (1999–2017), reporting per-procedure cost of $3,568 ($1,866 instruments, $1,038 system amortization, $663 service).

Internal cost-accounting studies and vendor service contract analysis (2024–2026).

• R2 Surgical market data on refurbished equipment pricing (May 2026).
• CMR Surgical and Medtronic product documentation and market positioning statements (2025–2026).

Disclaimer: This article reflects publicly verifiable pricing as of May 2026. Actual acquisition costs vary significantly by institution size, region, negotiating position, and service model. No manufacturer list prices are guaranteed; all figures represent market ranges observed in SEC filings, health-system contracts, and peer-reviewed literature. MedSource will update this article as additional competitive quotes accrue in our database.